Annexon: Preserving Patient Function Is The Real Investment Opportunity
Annexon targets functional recovery in geographic atrophy and Guillain-Barré syndrome, with ARCHER II vision-endpoint data due in Q4 2026…
Equity Eagle NASDAQ
Annexon, Inc.
ANNX
1 story
$734M Market cap · 2026-09-24
Equity Eagle 